Name | (S)-Methyl 2-(N-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoate |
---|---|
Synonyms |
methyl (2S)-3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoate
L-Valine, N-(1-oxopentyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, methyl ester Methyl N-pentanoyl-N-{[2'-(2H-tetrazol-5-yl)-4-biphenylyl]methyl}-L-valinate methyl N-pentanoyl-N-{[2'-(2H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valinate L-VALINE,N(1-OXOPENTYL)-N((2-(2H-TETRAZOL-5-YL) (1,1-BIPHENYL)-4-YL)METHYL)-METHYL ESTER Valsartan Methyl Ester Valsartan Impurity 13 |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 647.7±65.0 °C at 760 mmHg |
Molecular Formula | C25H31N5O3 |
Molecular Weight | 449.545 |
Flash Point | 345.5±34.3 °C |
Exact Mass | 449.242676 |
PSA | 101.07000 |
LogP | 5.31 |
Vapour Pressure | 0.0±1.9 mmHg at 25°C |
Index of Refraction | 1.566 |
RIDADR | NONH for all modes of transport |
---|
Precursor 0 | |
---|---|
DownStream 1 | |